Novocure
Janin K. is a Medical Communications Manager for EMEA at Novocure, focusing on glioblastoma since March 2020. Responsibilities include material production, organization, and approval, along with reviewing and proof-reading documents, contributing to congress organization, and supporting medical field staff. Prior experience includes working as a researcher at Kinderspital Zürich, managing patient samples for chimerism analyses and overseeing flow cytometric analysis for a clinical study. Janin K. completed a PhD in Immunology at the University of Zurich, where also served as a course instructor in molecular biology. Educational background includes a Master of Science in Biology from the University of Regensburg and a Bachelor of Science from Universität Rostock, alongside an exchange year at the University of Colorado Boulder.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.